Srinivas R. Nandana, Ph.D.
Affiliations: | 2010 | Vanderbilt University, Nashville, TN |
Area:
Cell Biology, OncologyGoogle:
"Srinivas Nandana"Parents
Sign in to add mentor| Robert J. Matusik | grad student | 2010 | Vanderbilt | |
| (Mouse models of prostate cancer progression and bone metastasis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tharp D, Nandana S. (2019) How Prostate Cancer Cells Use Strategy Instead of Brute Force to Achieve Metastasis. Cancers. 11: 1928 |
| Chu GC, Chung LWK, Gururajan M, et al. (2019) Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics. Asian Journal of Urology. 6: 65-81 |
| Tripathi M, Nandana S, Huang J, et al. (2019) Abstract 5164: Signaling crosstalk within prostate tumor microenvironment mediates castrate resistant disease progression Cancer Research |
| Nandana S, Gururajan M, Tripathi M, et al. (2019) Abstract 4523: A novel syngeneic mouse model of prostate cancer bone metastasis: Mechanisms of chemotaxis and bone colonization Cancer Research |
| Tripathi M, Nandana S, Billet S, et al. (2017) Modulation of cabozantinib efficacy by the prostate tumor microenvironment. Oncotarget. 8: 87891-87902 |
| Nandana S, Tripathi M, Duan P, et al. (2017) Bone metastasis of prostate cancer can be therapeutically targeted at the TBX2-WNT signaling axis. Cancer Research |
| Tripathi M, Nandana S, Huang J, et al. (2016) Abstract PR06: Reciprocal prostate cancer signaling with its microenvironment mediates castrate-resistant disease progression Cancer Research. 76 |
| Tripathi M, Nandana S, Billet S, et al. (2016) Abstract LB-274: Microenvironment mediates the efficacy of Cabozantinib in prostate cancer Cancer Research. 76 |
| Nandana S, Tripathi M, Duan P, et al. (2016) Abstract 4131: Blocking endogenous TBX2 abrogates prostate cancer bone metastasis through WNT signaling Cancer Research. 76: 4131-4131 |
| Gururajan M, Cavassani KA, Sievert M, et al. (2015) SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer. Oncotarget |